Vadivarhe Speciality Chemical substances () First Half 2023 Outcomes
Key Monetary Outcomes
- Income: ₹216.4m (up 119% from 1H 2022).
- Internet earnings: ₹1.68m (up from ₹40.1m loss in 1H 2022).
- Revenue margin: 0.8% (up from internet loss in 1H 2022). The transfer to profitability was pushed by larger income.
- EPS: ₹0.13 (up from ₹3.14 loss in 1H 2022).
All figures proven within the chart above are for the trailing 12 month (TTM) interval
Vadivarhe Speciality Chemical substances shares are up 4.9% from per week in the past.
Do not forget that there should still be dangers. For example, we have recognizedyou have to be conscious of.
Valuation is complicated, however we’re serving to make it easy.
Discover out whether or not Vadivarhe Speciality Chemical substances is doubtlessly over or undervalued by testing our complete evaluation, which incorporates truthful worth estimates, dangers and warnings, dividends, insider transactions and monetary well being.
Have suggestions on this text? Involved concerning the content material?with us immediately. Alternatively, e mail editorial-team (at) simplywallst.com.
This text by Merely Wall St is normal in nature. We offer commentary primarily based on historic knowledge and analyst forecasts solely utilizing an unbiased methodology and our articles aren’t meant to be monetary recommendation. It doesn’t represent a suggestion to purchase or promote any inventory, and doesn’t take account of your targets, or your monetary scenario. We goal to deliver you long-term centered evaluation pushed by elementary knowledge. Be aware that our evaluation might not issue within the newest price-sensitive firm bulletins or qualitative materials. Merely Wall St has no place in any shares talked about.